Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Cirrus Logic, Inc. today announced the appointment of Jeff Woolard as chief financial officer, effective February 24, 2025. Jeff has more than 30 years of experience in the technology industry with ...

The Board of Directors of Hammond-Henry Hospital in Geneseo have announced the appointment of a new Interim CEO Bradley ...

Profit rose in the fourth quarter compared to the same period of the previous year for French banking giant BNP Paribas. BNP ...

President Donald Trump on Tuesday proposed moving Gazans to a “good, fresh, beautiful piece of land” in another country, ...

"The blended (year-over-year) earnings growth rate for the S&P 500 is 13.2%," notes FactSet Senior Earnings Analyst John Butters. "If 13.2% is the actual growth rate for the quarter, it will mark the ...

FirstEnergy Corp. (NYSE: FE) received an Emergency Recovery Award from the Edison Electric Institute (EEI) in recognition of ...

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): AGM/EGM SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items 04.02.2025 / 18:22 CET/CEST The issuer is ...

Operator Good day, everyone and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being ...

Healthcare announced the appointment of Alison Wimms, Ph.D. as an advisor to its newly formed IHL-42X Obstructive Sleep Apnea ...

The World Health Organisation (WHO) has warned of a rising cancer burden, particularly in the South-East Asia region, where 2 ...